Echinacea Premium 60t
Couldn't load pickup availability
Description
Strengthen Your Immune Defense with Echinacea Premium
Echinacea Premium tablets combine two powerful forms of Echinacea—Echinacea angustifolia and Echinacea purpurea—both of which are renowned in traditional Western herbal medicine for their ability to relieve the severity of common cold symptoms. This potent formulation not only helps to alleviate discomfort from sneezing, runny nose, and cough, but also supports a healthy immune system response, making it an essential supplement during cold and flu season. Learn more about the benefits of Echinacea in our detailed guide.
Indications
- Traditionally used in Western herbal medicine to:
- Relieve the severity of common cold symptoms, including sneezing, runny nose, and cough
- Act as an alternative
- Helps stimulate a healthy immune system response as used in traditional Western herbal medicine.
Dose
Adults: 1 tablet 2-3 times daily.
Dosage may be increased for acute conditions.
Ingredients
| Each tablet contains: | Extract Volume | Equivalent Dry Root | Standardized Component (if applicable) |
|---|---|---|---|
| Echinacea angustifolia (Echinacea) | 1200 mcL | 600 mg | Alkylamides 2.26 mg |
| Echinacea purpurea (Echinacea) | 1350 mcL | 675 mg | None Specified |
Allergen Information
- No Added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds, artificial sweeteners, colours or flavours.
- Suitable for Vegans.
Excipients
Calcium Hydrogen Phosphate Dihydrate, Croscarmellose sodium, Hypromellose, Magnesium Stearate, and Microcrystalline Cellulose.
Warning
- Children under two years of age should not be treated for symptoms of respiratory tract infections without medical advice.
- The risk of allergic reaction to Echinacea is very small, especially if root preparations are used since these are free of pollens.
- Echinacea is contraindicated for long-term use in patients taking immunosuppressant medication (e.g., transplant patients) - short-term therapy only is suggested in this instance.
- Caution is advised in patients receiving midazolam by injection.
- Discontinue 7 days prior to general anaesthesia.
- If coughing persists, consult a healthcare professional.
- If patient symptoms persist, seek additional professional advice.
